Lipiarmycin-resistant Ribonucleic Acid Polymerase Mutants of Bacillus Subtilis
Overview
Affiliations
Lipiarmycin inhibited the activity of deoxyribonucleic acid-dependent ribonucleic acid (RNA) polymerase in vitro. We showed that inhibition was due to interference by lipiarmycin with the activity of sigma-containing molecules of RNA polymerase. Transcription by core enzyme was relatively resistant to the drug, but addition of sigma led to highly drug-sensitive RNA synthesis. We isolated lipiarmycin-resistant mutants of Bacillus subtilis and characterized them genetically and biochemically. Drug-resistant mutants contained an altered RNA polymerase that was resistant to the drug in vitro. By separation and mixed reconstitution of core and sigma fractions of mutant and wild-type RNA polymerase, we showed that lipiarmycin resistance in one mutant strain was a property of the core fraction. Genetic mapping experiments indicated that at least two lpm mutants are located between loci determining rifampin resistance and streptolydigin resistance.
Anwar A, Cain C, Garza M, Degen D, Ebright R, Del Valle J ChemMedChem. 2023; 19(1):e202300474.
PMID: 37751316 PMC: 10843019. DOI: 10.1002/cmdc.202300474.
RNA polymerases from low G+C gram-positive bacteria.
Miller M, Oakley A, Lewis P Transcription. 2021; 12(4):92-102.
PMID: 34403307 PMC: 8632073. DOI: 10.1080/21541264.2021.1964328.
Semisynthetic Analogs of the Antibiotic Fidaxomicin-Design, Synthesis, and Biological Evaluation.
Dorst A, Berg R, Gertzen C, Schafle D, Zerbe K, Gwerder M ACS Med Chem Lett. 2020; 11(12):2414-2420.
PMID: 33329763 PMC: 7734799. DOI: 10.1021/acsmedchemlett.0c00381.
Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3).
Lin W, Das K, Degen D, Mazumder A, Duchi D, Wang D Mol Cell. 2018; 70(1):60-71.e15.
PMID: 29606590 PMC: 6205224. DOI: 10.1016/j.molcel.2018.02.026.
Leeds J Cold Spring Harb Perspect Med. 2016; 6(2):a025445.
PMID: 26834162 PMC: 4743069. DOI: 10.1101/cshperspect.a025445.